Clinical Trials Browser

Carcinoma, Renal Cell × daratumumab × Clear all

NCT03473730 2025-01-30

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell, Urologic Neoplasms